Simultaneous Treatment with Azelnidipine and Olmesartan Inhibits Apoptosis of HI-1 Cardiac Myocytes Expressing E334k cMyBPC
- Author
- BAHRUDIN, U1 2 3 ; IKEDA, N1 ; RIFQI, S3 ; SHIRAYOSHI, Y1 ; YAMAMOTO, K5 ; NINOMIYA, H6 ; HISATOME, I1 ; UTAMI, S. B1 3 ; MAHARANI, N1 4 ; MORIKAWA, K1 ; LI, P1 ; SOBIRIN, M. A3 4 ; HASEGAWA, A1 ; SAKATA, S1 ; ENDO, R1
[1] Division of Regenerative Medicine and Therapeutics, Institute of Regenerative Medicine and Biofunction, Tottori University Graduate School of Medical Science, Yonago, Japan
[2] Center of Biomedical Research, Faculty of Medicine, Diponegoro University, Semarang, Indonesia
[3] Department of Cardiology and Vascular Medicine, Faculty of Medicine, Diponegoro University, Semarang, Indonesia
[4] Department of Pharmacology and Therapy, Faculty of Medicine, Diponegoro University, Semarang, Indonesia
[5] Department of Multidisciplinary Internal Medicine, School of Medicine, Tottori University, Yonago, Japan
[6] Department of Biological Regulation, Faculty of Medicine, Tottori University Yonago, Japan - Source
Drug research (Stuttgart. 2013. Print). 2013, Vol 63, Num 10, pp 515-520, 6 p ; ref : 38 ref
- ISSN
- 2194-9379
- Scientific domain
- Pharmacology drugs
- Publisher
- Thieme, Stuttgart
- Publication country
- Germany
- Document type
- Article
- Language
- English
- Author keyword
- angiotensin receptor blocker apoptosis calcium channel blocker hypertrophic cardiomyopathy mutant cardiac myosin binding protein C
- Keyword (fr)
- Antagoniste angiotensine Antagoniste calcium Antihypertenseur Apoptose Azelnidipine Cardiomyocyte Cardiomyopathie hypertrophique Coeur Inhibiteur Mort cellulaire Mutation Myosine Olmésartan Protéine C Protéine contractile Protéine liaison Traitement Anticoagulant naturel Récepteur AT1 de l'angiotensine II Appareil circulatoire Cardiopathie Dérivé de l'imidazole Dérivé de la dihydropyridine Dérivé du biphényle Dérivé du tétrazole Pathologie de l'appareil circulatoire Pathologie du myocarde Sartan dérivé
- Keyword (en)
- Angiotensin antagonist Calcium antagonist Antihypertensive agent Apoptosis Azelnidipine Cardiomyocyte Hypertrophic cardiomyopathy Heart Inhibitor Cell death Mutation Myosin Olmesartan Protein C Contractile protein Binding protein Treatment Natural anticoagulant Circulatory system Heart disease Imidazole derivatives Dihydropyridine derivatives Biphenyl derivatives Tetrazole derivatives Cardiovascular disease Myocardial disease Sartan derivatives
- Keyword (es)
- Antagonista angiotensina Antagonista calcio Antihipertensivo Apoptosis Azelnidipino Miocito cardíaco Cardiomiopatía hipertrófica Corazón Inhibidor Muerte celular Mutación Miosina Olmesartán Proteína C Proteína contráctil Proteína enlace Tratamiento Anticoagulante natural Aparato circulatorio Cardiopatía Imidazol derivado Dihidropiridine derivado Bifenilo derivado Tetrazol derivado Aparato circulatorio patología Miocardio patología Sartan derivado
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B12 Cardiology. Vascular system / 002B12A Heart / 002B12A05 Myocarditis. Cardiomyopathies
- Discipline
- Cardiology. Circulatory system
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 27843657
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1055/s-0033-1347188 
https://dx.doi.org/10.1055/s-0033-1347188
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:22:\"10.1055\/s-0033-1347188\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:123:\"Simultaneous Treatment with Azelnidipine and Olmesartan Inhibits Apoptosis of HI-1 Cardiac Myocytes Expressing E334k cMyBPC\";s:9:\"\u0000*\u0000jtitle\";s:38:\"Drug research (Stuttgart. 2013. Print)\";s:9:\"\u0000*\u0000stitle\";s:33:\"Drug. res. (Stuttg., 2013, Print)\";s:7:\"\u0000*\u0000date\";s:4:\"2013\";s:9:\"\u0000*\u0000volume\";s:2:\"63\";s:8:\"\u0000*\u0000issue\";s:2:\"10\";s:8:\"\u0000*\u0000spage\";s:3:\"515\";s:8:\"\u0000*\u0000epage\";s:3:\"520\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"2194-9379\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"BAHRUDIN\";s:10:\"\u0000*\u0000aufirst\";s:1:\"U\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:14:{i:0;s:8:\"IKEDA, N\";i:1;s:8:\"RIFQI, S\";i:2;s:13:\"SHIRAYOSHI, Y\";i:3;s:11:\"YAMAMOTO, K\";i:4;s:11:\"NINOMIYA, H\";i:5;s:11:\"HISATOME, I\";i:6;s:11:\"UTAMI, S. B\";i:7;s:11:\"MAHARANI, N\";i:8;s:11:\"MORIKAWA, K\";i:9;s:5:\"LI, P\";i:10;s:13:\"SOBIRIN, M. A\";i:11;s:11:\"HASEGAWA, A\";i:12;s:9:\"SAKATA, S\";i:13;s:7:\"ENDO, R\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:123:\"Simultaneous Treatment with Azelnidipine and Olmesartan Inhibits Apoptosis of HI-1 Cardiac Myocytes Expressing E334k cMyBPC\";s:8:\"\u0000*\u0000place\";s:9:\"Stuttgart\";s:6:\"\u0000*\u0000pub\";s:6:\"Thieme\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"6\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:22:\"10.1055\/s-0033-1347188\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:123:\"Simultaneous Treatment with Azelnidipine and Olmesartan Inhibits Apoptosis of HI-1 Cardiac Myocytes Expressing E334k cMyBPC\";s:9:\"\u0000*\u0000jtitle\";s:38:\"Drug research (Stuttgart. 2013. Print)\";s:9:\"\u0000*\u0000stitle\";s:33:\"Drug. res. (Stuttg., 2013, Print)\";s:7:\"\u0000*\u0000date\";s:4:\"2013\";s:9:\"\u0000*\u0000volume\";s:2:\"63\";s:8:\"\u0000*\u0000issue\";s:2:\"10\";s:8:\"\u0000*\u0000spage\";s:3:\"515\";s:8:\"\u0000*\u0000epage\";s:3:\"520\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"2194-9379\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"BAHRUDIN\";s:10:\"\u0000*\u0000aufirst\";s:1:\"U\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:14:{i:0;s:8:\"IKEDA, N\";i:1;s:8:\"RIFQI, S\";i:2;s:13:\"SHIRAYOSHI, Y\";i:3;s:11:\"YAMAMOTO, K\";i:4;s:11:\"NINOMIYA, H\";i:5;s:11:\"HISATOME, I\";i:6;s:11:\"UTAMI, S. B\";i:7;s:11:\"MAHARANI, N\";i:8;s:11:\"MORIKAWA, K\";i:9;s:5:\"LI, P\";i:10;s:13:\"SOBIRIN, M. A\";i:11;s:11:\"HASEGAWA, A\";i:12;s:9:\"SAKATA, S\";i:13;s:7:\"ENDO, R\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:123:\"Simultaneous Treatment with Azelnidipine and Olmesartan Inhibits Apoptosis of HI-1 Cardiac Myocytes Expressing E334k cMyBPC\";s:8:\"\u0000*\u0000place\";s:9:\"Stuttgart\";s:6:\"\u0000*\u0000pub\";s:6:\"Thieme\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"6\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:22:\"10.1055\/s-0033-1347188\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:22:\"10.1055\/s-0033-1347188\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:123:\"Simultaneous Treatment with Azelnidipine and Olmesartan Inhibits Apoptosis of HI-1 Cardiac Myocytes Expressing E334k cMyBPC\";s:9:\"\u0000*\u0000jtitle\";s:38:\"Drug research (Stuttgart. 2013. Print)\";s:9:\"\u0000*\u0000stitle\";s:33:\"Drug. res. (Stuttg., 2013, Print)\";s:7:\"\u0000*\u0000date\";s:4:\"2013\";s:9:\"\u0000*\u0000volume\";s:2:\"63\";s:8:\"\u0000*\u0000issue\";s:2:\"10\";s:8:\"\u0000*\u0000spage\";s:3:\"515\";s:8:\"\u0000*\u0000epage\";s:3:\"520\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"2194-9379\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"BAHRUDIN\";s:10:\"\u0000*\u0000aufirst\";s:1:\"U\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:14:{i:0;s:8:\"IKEDA, N\";i:1;s:8:\"RIFQI, S\";i:2;s:13:\"SHIRAYOSHI, Y\";i:3;s:11:\"YAMAMOTO, K\";i:4;s:11:\"NINOMIYA, H\";i:5;s:11:\"HISATOME, I\";i:6;s:11:\"UTAMI, S. B\";i:7;s:11:\"MAHARANI, N\";i:8;s:11:\"MORIKAWA, K\";i:9;s:5:\"LI, P\";i:10;s:13:\"SOBIRIN, M. A\";i:11;s:11:\"HASEGAWA, A\";i:12;s:9:\"SAKATA, S\";i:13;s:7:\"ENDO, R\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:123:\"Simultaneous Treatment with Azelnidipine and Olmesartan Inhibits Apoptosis of HI-1 Cardiac Myocytes Expressing E334k cMyBPC\";s:8:\"\u0000*\u0000place\";s:9:\"Stuttgart\";s:6:\"\u0000*\u0000pub\";s:6:\"Thieme\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"6\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:22:\"10.1055\/s-0033-1347188\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:123:\"Simultaneous Treatment with Azelnidipine and Olmesartan Inhibits Apoptosis of HI-1 Cardiac Myocytes Expressing E334k cMyBPC\";s:9:\"\u0000*\u0000jtitle\";s:38:\"Drug research (Stuttgart. 2013. Print)\";s:9:\"\u0000*\u0000stitle\";s:33:\"Drug. res. (Stuttg., 2013, Print)\";s:7:\"\u0000*\u0000date\";s:4:\"2013\";s:9:\"\u0000*\u0000volume\";s:2:\"63\";s:8:\"\u0000*\u0000issue\";s:2:\"10\";s:8:\"\u0000*\u0000spage\";s:3:\"515\";s:8:\"\u0000*\u0000epage\";s:3:\"520\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"2194-9379\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"BAHRUDIN\";s:10:\"\u0000*\u0000aufirst\";s:1:\"U\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:14:{i:0;s:8:\"IKEDA, N\";i:1;s:8:\"RIFQI, S\";i:2;s:13:\"SHIRAYOSHI, Y\";i:3;s:11:\"YAMAMOTO, K\";i:4;s:11:\"NINOMIYA, H\";i:5;s:11:\"HISATOME, I\";i:6;s:11:\"UTAMI, S. B\";i:7;s:11:\"MAHARANI, N\";i:8;s:11:\"MORIKAWA, K\";i:9;s:5:\"LI, P\";i:10;s:13:\"SOBIRIN, M. A\";i:11;s:11:\"HASEGAWA, A\";i:12;s:9:\"SAKATA, S\";i:13;s:7:\"ENDO, R\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:123:\"Simultaneous Treatment with Azelnidipine and Olmesartan Inhibits Apoptosis of HI-1 Cardiac Myocytes Expressing E334k cMyBPC\";s:8:\"\u0000*\u0000place\";s:9:\"Stuttgart\";s:6:\"\u0000*\u0000pub\";s:6:\"Thieme\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"6\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:22:\"10.1055\/s-0033-1347188\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:123:\"Simultaneous Treatment with Azelnidipine and Olmesartan Inhibits Apoptosis of HI-1 Cardiac Myocytes Expressing E334k cMyBPC\";s:9:\"\u0000*\u0000jtitle\";s:38:\"Drug research (Stuttgart. 2013. Print)\";s:9:\"\u0000*\u0000stitle\";s:33:\"Drug. res. (Stuttg., 2013, Print)\";s:7:\"\u0000*\u0000date\";s:4:\"2013\";s:9:\"\u0000*\u0000volume\";s:2:\"63\";s:8:\"\u0000*\u0000issue\";s:2:\"10\";s:8:\"\u0000*\u0000spage\";s:3:\"515\";s:8:\"\u0000*\u0000epage\";s:3:\"520\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"2194-9379\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"BAHRUDIN\";s:10:\"\u0000*\u0000aufirst\";s:1:\"U\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:14:{i:0;s:8:\"IKEDA, N\";i:1;s:8:\"RIFQI, S\";i:2;s:13:\"SHIRAYOSHI, Y\";i:3;s:11:\"YAMAMOTO, K\";i:4;s:11:\"NINOMIYA, H\";i:5;s:11:\"HISATOME, I\";i:6;s:11:\"UTAMI, S. B\";i:7;s:11:\"MAHARANI, N\";i:8;s:11:\"MORIKAWA, K\";i:9;s:5:\"LI, P\";i:10;s:13:\"SOBIRIN, M. A\";i:11;s:11:\"HASEGAWA, A\";i:12;s:9:\"SAKATA, S\";i:13;s:7:\"ENDO, R\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:123:\"Simultaneous Treatment with Azelnidipine and Olmesartan Inhibits Apoptosis of HI-1 Cardiac Myocytes Expressing E334k cMyBPC\";s:8:\"\u0000*\u0000place\";s:9:\"Stuttgart\";s:6:\"\u0000*\u0000pub\";s:6:\"Thieme\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"6\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
